The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preclinical Imaging (In-VIVO)-Global Market Insights and Sales Trends 2024
Synopsis
The global Preclinical Imaging (In-VIVO) market size is expected to reach US$ 892.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Imaging (In-VIVO) in various end use industries. The expanding demands from the Oncology, Cardio and Vascular, Neurology and Others, are propelling Preclinical Imaging (In-VIVO) market. Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagent segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preclinical Imaging (In-VIVO) market, driven by demand from China, the second largest economy with some signs of stabilising, the Preclinical Imaging (In-VIVO) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Imaging (In-VIVO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Imaging (In-VIVO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Imaging (In-VIVO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Imaging (In-VIVO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Imaging (In-VIVO) covered in this report include PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences and Trifoil Imaging, etc.
The global Preclinical Imaging (In-VIVO) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
Global Preclinical Imaging (In-VIVO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Imaging (In-VIVO) market, Segment by Type:
Equipment
Reagent
Global Preclinical Imaging (In-VIVO) market, by Application
Oncology
Cardio and Vascular
Neurology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical Imaging (In-VIVO) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Preclinical Imaging (In-VIVO) market size is expected to reach US$ 892.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Imaging (In-VIVO) in various end use industries. The expanding demands from the Oncology, Cardio and Vascular, Neurology and Others, are propelling Preclinical Imaging (In-VIVO) market. Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagent segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preclinical Imaging (In-VIVO) market, driven by demand from China, the second largest economy with some signs of stabilising, the Preclinical Imaging (In-VIVO) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Imaging (In-VIVO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Imaging (In-VIVO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Imaging (In-VIVO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Imaging (In-VIVO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Imaging (In-VIVO) covered in this report include PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences and Trifoil Imaging, etc.
The global Preclinical Imaging (In-VIVO) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
Global Preclinical Imaging (In-VIVO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Imaging (In-VIVO) market, Segment by Type:
Equipment
Reagent
Global Preclinical Imaging (In-VIVO) market, by Application
Oncology
Cardio and Vascular
Neurology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical Imaging (In-VIVO) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preclinical Imaging (In-VIVO)
1.1 Preclinical Imaging (In-VIVO) Market Overview
1.1.1 Preclinical Imaging (In-VIVO) Product Scope
1.1.2 Preclinical Imaging (In-VIVO) Market Status and Outlook
1.2 Global Preclinical Imaging (In-VIVO) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preclinical Imaging (In-VIVO) Market Size by Region (2018-2029)
1.4 Global Preclinical Imaging (In-VIVO) Historic Market Size by Region (2018-2023)
1.5 Global Preclinical Imaging (In-VIVO) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preclinical Imaging (In-VIVO) Market Size (2018-2029)
1.6.1 North America Preclinical Imaging (In-VIVO) Market Size (2018-2029)
1.6.2 Europe Preclinical Imaging (In-VIVO) Market Size (2018-2029)
1.6.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size (2018-2029)
1.6.4 Latin America Preclinical Imaging (In-VIVO) Market Size (2018-2029)
1.6.5 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size (2018-2029)
2 Preclinical Imaging (In-VIVO) Market by Type
2.1 Introduction
2.1.1 Equipment
2.1.2 Reagent
2.2 Global Preclinical Imaging (In-VIVO) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Type (2018-2023)
2.2.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preclinical Imaging (In-VIVO) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preclinical Imaging (In-VIVO) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preclinical Imaging (In-VIVO) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preclinical Imaging (In-VIVO) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preclinical Imaging (In-VIVO) Revenue Breakdown by Type (2018-2029)
3 Preclinical Imaging (In-VIVO) Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardio and Vascular
3.1.3 Neurology
3.1.4 Others
3.2 Global Preclinical Imaging (In-VIVO) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Application (2018-2023)
3.2.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preclinical Imaging (In-VIVO) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preclinical Imaging (In-VIVO) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preclinical Imaging (In-VIVO) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preclinical Imaging (In-VIVO) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preclinical Imaging (In-VIVO) Revenue Breakdown by Application (2018-2029)
4 Preclinical Imaging (In-VIVO) Competition Analysis by Players
4.1 Global Preclinical Imaging (In-VIVO) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2022)
4.3 Date of Key Players Enter into Preclinical Imaging (In-VIVO) Market
4.4 Global Top Players Preclinical Imaging (In-VIVO) Headquarters and Area Served
4.5 Key Players Preclinical Imaging (In-VIVO) Product Solution and Service
4.6 Competitive Status
4.6.1 Preclinical Imaging (In-VIVO) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 PerkinElmer
5.1.1 PerkinElmer Profile
5.1.2 PerkinElmer Main Business
5.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.1.4 PerkinElmer Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.1.5 PerkinElmer Recent Developments
5.2 Bruker Corporation
5.2.1 Bruker Corporation Profile
5.2.2 Bruker Corporation Main Business
5.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.2.4 Bruker Corporation Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.2.5 Bruker Corporation Recent Developments
5.3 FUJIFILM Holdings
5.3.1 FUJIFILM Holdings Profile
5.3.2 FUJIFILM Holdings Main Business
5.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.3.4 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.3.5 Mediso Recent Developments
5.4 Mediso
5.4.1 Mediso Profile
5.4.2 Mediso Main Business
5.4.3 Mediso Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.4.4 Mediso Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.4.5 Mediso Recent Developments
5.5 MILabs B.V.
5.5.1 MILabs B.V. Profile
5.5.2 MILabs B.V. Main Business
5.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.5.4 MILabs B.V. Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.5.5 MILabs B.V. Recent Developments
5.6 MR Solutions
5.6.1 MR Solutions Profile
5.6.2 MR Solutions Main Business
5.6.3 MR Solutions Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.6.4 MR Solutions Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.6.5 MR Solutions Recent Developments
5.7 Aspect Imaging
5.7.1 Aspect Imaging Profile
5.7.2 Aspect Imaging Main Business
5.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.7.4 Aspect Imaging Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.7.5 Aspect Imaging Recent Developments
5.8 LI-COR Biosciences
5.8.1 LI-COR Biosciences Profile
5.8.2 LI-COR Biosciences Main Business
5.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.8.4 LI-COR Biosciences Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.8.5 LI-COR Biosciences Recent Developments
5.9 Trifoil Imaging
5.9.1 Trifoil Imaging Profile
5.9.2 Trifoil Imaging Main Business
5.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.9.4 Trifoil Imaging Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.9.5 Trifoil Imaging Recent Developments
5.10 Miltenyi Biotec
5.10.1 Miltenyi Biotec Profile
5.10.2 Miltenyi Biotec Main Business
5.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Products, Services and Solutions
5.10.4 Miltenyi Biotec Preclinical Imaging (In-VIVO) Revenue (US$ Million) & (2018-2023)
5.10.5 Miltenyi Biotec Recent Developments
6 North America
6.1 North America Preclinical Imaging (In-VIVO) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preclinical Imaging (In-VIVO) Market Dynamics
11.1 Preclinical Imaging (In-VIVO) Industry Trends
11.2 Preclinical Imaging (In-VIVO) Market Drivers
11.3 Preclinical Imaging (In-VIVO) Market Challenges
11.4 Preclinical Imaging (In-VIVO) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
